Background and Purpose-Maternal cigarette smoking increases the risk of neonatal morbidity. We tested the hypothesis that perinatal nicotine exposure causes heightened brain vulnerability to hypoxic-ischemic (HI) injury in neonatal rats through aberrant expression patterns of angiotensin II type 1 (AT 1 R) and type 2 (AT 2 R) receptors in the developing brain. Methods-Nicotine was administered to pregnant rats through subcutaneous osmotic minipumps. HI brain injury was determined in 10-day-old pups. AT 1 R and AT 2 R expression patterns were assessed through Western blotting, quantitative polymerase chain reaction, immunofluorescence, and confocal imaging. Results-Perinatal nicotine exposure significantly increased HI brain infarct size in male, but not female, pups. In fetal brains, nicotine caused a decrease in mRNA and protein abundance of AT 2 R but not AT 1 R. The downregulation of AT 2 R persisted in brains of male pups, and nicotine treatment resulted in a significant increase in methylation of CpG locus 3 bases upstream of TATA-box at the AT 2 R gene promoter. In female brains, there was an increase in AT 2 R but a decrease in AT 1 R expression. Both AT 1 R and AT 2 R expressed in neurons but not in astrocytes in the cortex and hippocampus. Central application of AT 1 R antagonist losartan or AT 2 R antagonist PD123319 increased HI brain infarct size in both male and female pups. In male pups, AT 2 R agonist CGP42112 abrogated nicotine-induced increase in HI brain infarction. In females, PD123319 uncovered the nicotine's effect on HI brain infarction. Key Words: AT 1 R/AT 2 R Ⅲ hypoxic-ischemic brain injury Ⅲ neonatal rat Ⅲ nicotine H ypoxic-ischemic encephalopathy (HIE) occurs in one to 6 per 1000 term newborns and causes severe mortality and long-lasting morbidity, including cerebral palsy, seizure, and cognitive retardation in infants and children. 1,2 Although the underlying mechanisms of heightened brain vulnerability to hypoxic-ischemic (HI) injury in newborns remain largely elusive, recent studies suggest a possible cause of aberrant brain development due to fetal insults. 3 Maternal cigarette smoking is the single most widespread perinatal insult in the world. As one of the major components in cigarette smoking, nicotine readily crosses the placenta and produces higher nicotine concentrations in the fetal circulation than that experienced by the mother. 4 Epidemiological and animal studies have provided evidence linking perinatal nicotine exposure and the increased incidence of neurodevelopmental disorders, neurobehavioral deficits, impaired cognitive performance, and increased risk of affective disorders later in life. 5, 6 However, whether and to what extent perinatal nicotine exposure adversely affects the brain susceptibility to HI injury in newborns remains unknown. The present study tested the hypothesis that maternal nicotine administration during gestation results in heightened brain vulnerability to HI injury in neonatal rats. Given that the brain renin-angiotensin system plays a vital role in the development and progression of cerebrovascular diseases, and both angiotensin II type 1 (AT 1 R) and type 2 (AT 2 R) receptors are pivotal players in the pathogenesis of ischemic brain injury, 7-9 we sought to investigate further the role of AT 1 R and AT 2 R in the nicotine-mediated ischemia-sensitive phenotype of neo- 
H ypoxic-ischemic encephalopathy (HIE) occurs in one to 6 per 1000 term newborns and causes severe mortality and long-lasting morbidity, including cerebral palsy, seizure, and cognitive retardation in infants and children. 1, 2 Although the underlying mechanisms of heightened brain vulnerability to hypoxic-ischemic (HI) injury in newborns remain largely elusive, recent studies suggest a possible cause of aberrant brain development due to fetal insults. 3 Maternal cigarette smoking is the single most widespread perinatal insult in the world. As one of the major components in cigarette smoking, nicotine readily crosses the placenta and produces higher nicotine concentrations in the fetal circulation than that experienced by the mother. 4 Epidemiological and animal studies have provided evidence linking perinatal nicotine exposure and the increased incidence of neurodevelopmental disorders, neurobehavioral deficits, impaired cognitive performance, and increased risk of affective disorders later in life. 5, 6 However, whether and to what extent perinatal nicotine exposure adversely affects the brain susceptibility to HI injury in newborns remains unknown. The present study tested the hypothesis that maternal nicotine administration during gestation results in heightened brain vulnerability to HI injury in neonatal rats. Given that the brain renin-angiotensin system plays a vital role in the development and progression of cerebrovascular diseases, and both angiotensin II type 1 (AT 1 R) and type 2 (AT 2 R) receptors are pivotal players in the pathogenesis of ischemic brain injury, [7] [8] [9] we sought to investigate further the role of AT 1 R and AT 2 R in the nicotine-mediated ischemia-sensitive phenotype of neo-natal brains. We present evidence of a novel finding that perinatal nicotine exposure causes epigenetic programming of AT 2 R gene repression in the developing brain resulting in the increased brain susceptibility to HI injury in neonatal male rats in a sex-dependent manner and suggest new insights of molecular mechanisms linking maternal cigarette smoking to heightened HIE vulnerability in newborns.
Materials and Methods

Experimental Animals
Pregnant Sprague-Dawley rats were purchased from Charles River Laboratories (Portage, MI) and were randomly divided into 2 groups: (1) saline control; and (2) nicotine administration through osmotic minipumps (4 g/kg/min) implanted subcutaneously from Day 4 of gestation to Day 10 after birth. 10 On Day 21 of pregnancy, some rats were euthanized and fetal (E21) brains were isolated. Other rats were allowed to give birth, and further studies were conducted in 10-dayold neonatal (P10) pups of both sexes. All procedures and protocols were approved by the Institutional Animal Care and Use Committee of Loma Linda University and followed the guidelines by the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Brain HI Treatment and Intracerebroventricular Injection
A modified Rice-Vannucci model was conducted in P10 pups. 11 Pups were anesthetized with 2% isoflurane and the right common carotid artery was ligated. After recovery for 1 hour, pups were treated with 8% O 2 for 1.5 or 2.5 hours. To determine the role of AT 1 R and AT 2 R in brain HI injury, AT 1 R antagonist losartan (Merck), AT 2 R antagonist PD123319 (Sigma-Aldrich), and AT 2 R selective agonist CGP42112 (TOCRIS Bioscience) were administered intracerebroventricularly, respectively, before the HI treatment. Pups were anesthetized and fixed on a stereotaxic apparatus (Stoelting, Wood Dale, IL). An incision was made on the skull surface and bregma was exposed. All agents were injected at a rate of 1 L/min with a 10-L syringe (Stoelting) on the right hemisphere following the coordinates relative to bregma: 2 mm posterior, 1.5 mm lateral, and 3.0 mm below the skull surface. 12 Saline was injected as a control. The injection lasted 2 minutes and the needle was kept for additional 5 minutes before its removal. The incision was sutured.
Infarct Size Measurement
Pups were anesthetized and euthanized 48 hours after the HI treatment. Coronal slices of the brain (2 mm thick) were cut and immersed in a 2% solution of 2,3,5-triphenyltetrazolium chloride monohydrate (Sigma-Aldrich) for 5 minutes at 37°C and then fixed by 10% formaldehyde overnight. Each slice was weighed, photographed separately, and the percentage of infarction area for each slice was analyzed by Image J software (Version 1.40; National Institutes of Health, Bethesda, MD), corrected by slice weight, summed for each brain, and expressed as a percentage of whole brain weight.
Western Immunoblotting
Brains were homogenized in a lysis buffer containing 150 mmol/L NaCl, 50 mmol/L Tris HCl, 10 mmol/L EDTA, 0.1% Tween-20, 1% Triton, 0.1% ␤-mercaptoethanol, 0.1 mmol/L phenylmethylsulfonyl fluoride, 5 g/mL leupeptin, and 5 g/mL aprotinin, pH 7.4. Homogenates were centrifuged at 4°C for 10 minutes at 10 000 g, and supernatants collected. Protein concentrations were determined using a protein assay kit (Bio-Rad, Hercules, CA). Samples with equal amounts of protein were loaded onto 10% polyacrylamide gel with 0.1% sodium dodecyl sulfate and separated by electrophoresis at 100 V for 90 minutes. Proteins were then transferred onto nitrocellulose membranes and probed with primary antibodies against AT 1 R (1:100) and AT 2 R (1:1000; Santa Cruz Biotechnology; Santa Cruz, CA) as described previously. 13 After washing, membranes were incubated with secondary horseradish peroxidaseconjugated antibodies. Proteins were visualized with enhanced chemiluminescence reagents, and blots were exposed to Hyperfilm. The results were analyzed with Kodak ID image analysis software. Band intensities were normalized to glyceraldehyde-3-phosphate dehydrogenase.
Real-Time Reverse Transcription-Polymerase Chain Reaction
RNA was extracted from brains and abundance of AT 1a R, AT 1b R, and AT 2 R mRNA was determined by real-time reverse transcription-polymerase chain reaction using an Icycler Thermal cycler (Bio-Rad, Hercules, CA), as described previously. 13 The primers used were: AT 1a R, 5Ј-ggagaggattcgtggcttgag-3Ј (forward) and 5Ј-ctttctgggagggttgtgtgat-3Ј (reverse); AT 1b R , 5Ј-atgtctccagtcccctctca-3Ј (forward) and 5Ј-tgacctcccatctccttttg-3Ј (reverse); and AT 2 R, 5Ј-caatctggctgtggctgactt-3Ј (forward) and 5Ј-tgcacatcacaggtccaaaga-3Ј (reverse). Real-time reverse transcription-polymerase chain reaction was performed in a final volume of 25 L. Each polymerase chain reaction mixture consisted of 600 nmol/L of primers, 33 U of M-MLV reverse transcriptase (Promega, Madison, WI), and iQ SYBR Green Supermix (Bio-Rad) containing 0.625 U Taq polymerase, 400 mol/L each of dATP, dCTP, dGTP, and dTTP, 100 mmol/L KCl, 16.6 mmol/L ammonium sulfate, 40 mmol/L Tris-HCl, 6 mmol/L MgSO 4 , SYBR Green I, 20 nmol/L fluorescing, and stabilizers. The following reverse transcription-polymerase chain reaction protocol was used: 42°C for 30 minutes, 95°C for 15 minutes followed by 40 cycles of 95°C for 20 seconds, 56°C for 1 minute, 72°C for 20 seconds. Glyceraldehyde-3-phosphate dehydrogenase was used as an internal reference and serial dilutions of the positive control was performed on each plate to create a standard curve. Polymerase chain reaction was performed in triplicate, and threshold cycle numbers were averaged.
Quantitative Methylation-Specific Polymerase Chain Reaction
CpG methylation at rat AT 2 R gene promoter was determined as previously described. 10, 14 Briefly, genomic DNA was isolated from brains of P10 pups using a GenElute Mammalian Genomic DNA Mini-Prep kit (Sigma), denatured with 2 N NaOH at 42°C for 15 minutes, treated with sodium bisulfite at 55°C for 16 hours, and purified by EZ DNA Methylation-Gold Kit (Zymo Research), as previously described. Bisulfite-treated DNA was used as a template for real-time fluorogenic methylation-specific polymerase chain reaction at CpG -52 locus (forward primer, 5Ј-ttttttggaaagttggtaagtgttta-3Ј; reverse primer for C, 5Ј-ctctaatttccttcttatatattca-3Ј; reverse primer for C m , 5Ј-ctctaatttccttcttatatattcg-3Ј) and CpG ϩ11 locus (forward primer, 5Ј-gaaggttttttagtggatag-3Ј; reverse primer for C, 5Ј-aaaaaaaactttcaattctatactca-3Ј; reverse primer for C m , 5Ј-aaaaaaaactttcaattctatactcg-3Ј), respectively. Glyceraldehyde-3-phosphate dehydrogenase was used as an internal reference gene. Real-time methylation-specific polymerase chain reaction was performed using the iQ SYBR Green Supermix with iCycler real-time polymerase chain reaction system (Bio-Rad). Data are presented as the percent of methylation at the region of interest (methylated CpG/methylated CpGϩunmethylated CpGϫ100), as described previously. 10, 14 
Immunofluorescence Staining and Confocal Imaging
Brains were fixed in formalin and processed to obtain 10-m tissue slides. Antigens were retrieved with antigen retrieval buffer (Abcam) after heat-induced procedures. The following primary antibodies were used: mouse antineuronal nuclei (Millipore); mouse anti glial fibrillary acidic protein (Millipore); rabbit anti-AT 1 R (Santa Cruz); and rabbit anti-AT 2 R (Santa Cruz). After blocking with 1% bovine serum albumin for 2 hours at room temperature and incubation with the primary antibodies at 4°C overnight, tissue sections were treated with secondary antibodies raised against mouse and rabbit IgG conjugated with fluorescein isothiocyanate and Texas Red (Santa Cruz), respectively, for 2 hours at room temperature. After 3 washes, sections were stained with Hoechst 33258 (5 g/mL; Sigma) for 1 minute. The sections were then covered with Permount reagent (Fisher) and visualized using the Zeiss LSM 710 confocal microscope, as previously described. 15 
Statistical Analysis
Data are expressed as meanϮSEM. Experimental number (n) represents fetuses and neonates from different dams. Statistical significance (PϽ0.05) was determined by analysis of variance followed by Neuman-Keuls post hoc testing or Student t test, where appropriate.
Results
Nicotine Caused Asymmetrical Growth Restriction in Fetuses and Neonates
Maternal nicotine administration caused a significant decrease in the body weight, but not the brain weight, in E21 fetuses, resulting in a significant increase in the brain to body weight ratio ( Figure 1A) . In P10 pups, both body and brain weight were decreased but the brain to body weight ratio remained significantly increased in both sexes ( Figure 1B) , suggesting asymmetrical growth restriction in the fetus and neonate in nicotine-treated animals.
Nicotine Increased Brain Vulnerability to HI Injury in Male Pups
In control animals, there was no significant difference in HI-induced brain infarct size between male and female pups (Figure 2 ). The nicotine treatment significantly exaggerated HI-induced brain infarct size in male, but not female, pups (Figure 2 ).
Nicotine Altered Expression Patterns of AT 1 R and AT 2 R in Fetal and Neonatal Brains
In E21 fetuses, the nicotine treatment resulted in a significant decrease in brain AT 2 R protein and mRNA abundance ( Figure 3A-B) . There was no significant effect of nicotine on AT 1 R protein abundance with a significant decrease in AT 1a R mRNA but an increase in AT 1b R mRNA abundance in the fetal brain ( Figure 3B ). In P10 pups, brain AT 2 R protein and mRNA abundance were significantly decreased in male pups 
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in nicotine-treated animals ( Figure 3C-D) . In contrast, in female pups, nicotine caused a significant increase in brain AT 2 R protein and mRNA abundance ( Figure 3C-D) . There was no significant effect of nicotine on brain AT 1 R protein, AT 1a R, and AT 1b R mRNA abundance in male pups ( Figure  3C-D) . However, nicotine induced a significant reduction of brain AT 1 R protein and AT 1a R mRNA abundance in female pups ( Figure 3C-D) . Immunofluorescence and confocal imaging analyses showed that both AT 1 R and AT 2 R presented in neurons but not in astrocytes in the cortex (online-only Data Supplement Figure I ) and hippocampus (online-only Data Supplement Figure II ) of P10 pups. It appeared that nicotine treatment increased astrocyte numbers in both cortex and hippocampus (online-only Data Supplement Figure III) .
AT 1 R and AT 2 R Protected Neonatal Rat Brains From HI Injury
To determine the functional significance of altered AT 1 R and AT 2 R expression patterns in nicotine-induced, heightened brain vulnerability to HI injury in neonates, we first evaluated the role of AT 1 R and AT 2 R in the pathogenesis of HI brain injury in pups through intracerebroventricular (ICV) injection of AT 1 R or AT 2 R antagonists. Compared with the saline control, ICV of either losartan ( Figure 4A ) or PD123319 ( Figure 4B ) significantly increased brain infarct size in both male and female pups, suggesting that both AT 1 R and AT 2 R may be implicated in the pathogenesis of HI brain injury and confer neuroprotective properties in neonatal rat brains.
AT 2 R Played a Key Role in Nicotine-Induced, Heightened Brain Vulnerability to HI Injury in Pups
To demonstrate the cause and effect relation between nicotine-induced downregulation of brain AT 2 R and heightened brain vulnerability to HI injury in male pups, a selective AT 2 R agonist, CGP42112, was administered in male pups that had been treated with nicotine or saline control. As shown in Figure 5A , ICV administration of CGP42112 (3 g) reversed the effect of nicotine and abrogated the difference in HI-induced brain infarct size between saline control and nicotine-treated male pups. The key role of brain AT 2 R in nicotine-induced heightened brain vulnerability to HI injury in neonatal rats was further tested in female pups with ICV administration of PD123319. As shown in Figure 5B , in the absence of PD123319, the nicotine treatment had no significant effect on brain HI injury in female pups. However, in the presence of PD123319 (5 g), the effect of nicotine was uncovered and HI-induced brain infarct size was significantly increased in nicotine-treated, as compared with saline control, female pups ( Figure 5B ). 
Nicotine Treatment Increased Methylation of CpG -52 Locus at AT 2 R Promoter
Recently, we have demonstrated that rat AT 2 R promoter has a TATA element at Ϫ48 from transcription start site, and deletion of the TATA element significantly decreases the promoter activity. 13 Two CpG loci were identified at the AT 2 R promoter; one was located 3 bases upstream of TATA-box (CpG -52 ) and the other one 11 bases downstream of transcription start site (CpG ϩ11 ). The previous study showed that increased methylation at CpG locus 3 bases upstream of TATA-box inhibited the binding of the TATAbox binding protein and decreased promoter activity. 16 As shown in Figure 6 , nicotine treatment caused a significant increase in methylation of CpG -52 locus in male but not female pup brains, whereas methylation of CpG ϩ11 locus was not significantly affected.
Discussion
The new findings of the present study are: (1) perinatal nicotine exposure significantly increases brain vulnerability to HI injury in male rat pups, but not in female pups; (2) this heightened vulnerability is associated with sex-specific reprogramming of AT 1 R and AT 2 R expression patterns in the developing brain; (3) both AT 1 R and AT 2 R are implicated in the pathogenesis of HI brain injury and exhibit the neuroprotective effect in neonatal brains; (4) downregulation of AT 2 R in the developing brain plays a causal role in nicotineinduced, heightened brain vulnerability to HI injury in neonatal rats; and (5) increased methylation of CpG locus 3 bases upstream of TATA-box at the AT 2 R promoter is a mechanism of nicotine-mediated AT 2 R gene repression. The present finding that perinatal nicotine exposure increased brain HI injury in neonates is novel and suggests a risk factor of maternal cigarette smoking in heightened brain HIE vulnerability in newborns. The nicotine dose used in the present study resulted in blood nicotine concentrations similar to those found in humans who smoke or use nicotine gum and patch. 4, 17 Nicotine readily crosses the placenta into the fetal circulation, resulting in fetal nicotine concentrations being 15% higher than maternal levels. 18 It is unclear at present whether observed effects are caused by vascular effects or direct neuronal effects of nicotine. Although it may be technically challenging in measuring cerebral blood flow in neonatal rats, possible alterations in cerebral blood flow caused by nicotine treatment deserve further investigation.
The Rice-Vannucci model of unilateral common carotid artery ligation followed by 2.5 to 3 hours of 8% oxygen treatment produces extensive brain damage in neonatal rats and is widely used in studies of potential therapeutic intervention. However, few studies examined the brain susceptibility to mild HI injury in neonates, which may present only subtle differences and require more sophisticated experimental procedures. In the present study, a shorter treatment period of pups with 8% oxygen for 1.5 hours produced mild brain damage of approximately 10% infarction in the ipsilateral hemisphere. This mild and clinically relevant brain HI injury was significantly increased by Ͼ2-fold in nicotine-treated male pups. However, the longer period of hypoxic treatment with greater brain damage in the model masked the effect of nicotine, suggesting a critical importance of appropriate model in investigating subtle changes of heightened brain vulnerability of HIE in newborns.
The growth restriction found in nicotine-treated animals presents a possible link between perinatal nicotine exposure and enhanced brain HI injury in pups given that intrauterine growth restriction is a risk factor of neonatal encephalopathy. 19 Fetal hypoxia may be another possible factor enhancing the nicotine-mediated effects. Although intermittent injections of nicotine to the mother may produce episodic fetal hypoxia and a decrease in cerebral perfusion with a reduced fetal brain weight, 20 -22 these effects were not observed in continuous low-level infusion of nicotine through a minipump. 17 The finding that ICV application of both AT 1 R and AT 2 R antagonists enhanced the severity of brain HI injury is intriguing and suggests that both AT 1 R and AT 2 R are neuroprotective in the setting of neonatal HI brain injury. Both AT 1 R and AT 2 R present in the brain with specific developmental and spatial expression patterns. In adult brains, the AT 1 R predominates, whereas fetal brains express high levels of AT 2 R that decrease during the postnatal development. 23 The present study demonstrated that both AT 1 R and AT 2 R expressed exclusively in neurons in both cortex and hippocampus in neonatal rat brains, whereas AT 1 R expressed predominantly in astrocytes in adult brains. 24 The neuroprotective effect of AT 2 R demonstrated in the present study is consistent with previous findings. 24 -26 In contrast, the present finding of a neuroprotective effect of AT 1 R in neonatal brains is somewhat surprising given that AT 1 R antagonists have been shown to exhibit neuroprotection in adult rat brains. 9, [27] [28] [29] These findings highlight the important differences between immature and mature brains in AT 1 Rmediated responses. It has been shown that apoptotic cell death is more prominent in immature brains to HI insult, but necrotic cell death is more common in adult brains in response to acute insults such as HI or excitotoxicity. 30, 31 Although long-term and systemic administration of AT 1 R antagonists often showed neuroprotective effects of the brain through multiple systemic effects, the acute and local direct effects of AT 1 R antagonists in modulating brain HI injury are indeed less clear and may be quite different from those seen in the long-term and systemic effects. Indeed, similar to the present finding, the previous studies demonstrated a direct adverse effect of local administration of AT 1 R antagonists in the setting of acute ischemic injury in the heart 13,32 despite well-documented protective effects of long-term and systemic administration of AT 1 R blockers in preventing the deleterious consequences of ischemia and reperfusion injury and reducing cardiac remodeling.
Of importance, the present study demonstrated that perinatal nicotine exposure-mediated, heightened brain vulnerability to HI injury in male pups was associated with a significant decrease in brain AT 2 R expression. Additionally, the ICV administration of the AT 2 R agonist CGP42112 abrogated nicotine's effect. It has been demonstrated that direct stimulation of AT 2 R in the brain with CGP42112 confers neuroprotective effects in a conscious rat model of stroke, which is beyond blood pressure regulation. 26 These results provide evidence of a causal role of AT 2 R downregulation in the nicotine-induced increase in brain HI injury in the pups. Our recent study has revealed that rat AT 2 R promoter has a TATA element at Ϫ48 from transcription start site and deletion of the TATA-box significantly decreases the promoter activity. 13 The finding that nicotine treatment significantly increased methylation of CpG -52 locus 3 bases upstream of TATA-box at the AT 2 R promoter in male pup brains is intriguing and suggests an important mechanism of site-specific CpG methylation in epigenetic repression of AT 2 R gene in the developing brain. It has been demonstrated that increased methylation at CpG locus 3 bases upstream of TATA-box inhibits the binding of the TATA-box binding protein and decreases receptor activator of nuclear factor-B ligand gene promoter activity. 16 Unlike CpG -52 locus, methylation of CpG ϩ11 locus was not significantly altered, suggesting its minimal role in programming of AT 2 R gene expression patterns in the brain. Perinatal nicotine-mediated increase in sequence-specific CpG methylation has recently been demonstrated in the Egr-1 binding site at PKC⑀ promoter in the developing heart, which causes PKC⑀ gene repression. 10 Interestingly, nicotine had no significant effect on methylation of CpG -52 locus in female pup brains, demonstrating a sex-specific effect at a developmental period that sex hormonal influences are minimal. This suggests there are transcriptional distinctions that are wired in males and females long before sex steroids are involved. Similar findings of sex-specific CpG methylation and epigenetic repression of the PKC⑀ gene were obtained in male fetal rat hearts in response to hypoxia, in which the greater expression of estrogen receptors in female fetuses may convey a protection in stress-mediated epigenetic modifications. 14 In the present study, the mechanism of increased AT 2 R expression in female pup brains is not clear at present. A possible mechanism is that stress-mediated downregulation of glucocorticoid receptors may contribute to the upregulation of AT 2 R, as shown recently in fetal rat hearts. 13 Additionally, it has been shown that estrogen receptors mediate the downregulation of AT 1 R but upregulation of AT 2 R in rodents. [33] [34] [35] Consistent with the present findings, sex differences in perinatal stressmediated epigenetic programming of gene expression patterns and subsequent disease development have been well reported previously with males often being prone to be at higher risk of disease development at an earlier age than females. 36 -39 The present investigation provides novel evidence that perinatal nicotine exposure increases brain susceptibility to HI injury through reprogramming of AT 1 R and AT 2 R expression patterns in rat pups. Although it may be difficult to translate the present findings directly into humans, the possibility that antenatal stresses may result in programming of specific gene expression patterns in the developing brain resulting in heightened vulnerability of newborn brains to HI injury provides a mechanistic understanding worthy of investigation in humans. The clinical significance of the present study is warranted because maternal cigarette smoking and use of nicotine gum and patch during gestation present a major stress to the developing fetus and because HIE in newborns causes severe mortality and long-lasting morbidity yet the underlying mechanisms remain largely elusive. Further studies on the epigenetic regulation of AT 1 R and AT 2 R gene expression patterns in the developing brain should provide more insights into mechanisms at the molecular level and may suggest new insights of therapeutic strategies that may be beneficial for the treatment of HIE in newborns.
